BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹29 Cr | ₹22 Cr | ₹16 Cr | ₹15 Cr | ₹17 Cr |
What is the latest Appropriations of BAL PHARMA ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹29 Cr |
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹16 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹17 Cr |
How is Appropriations of BAL PHARMA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹29 Cr | 33.11 | |
| Mar2025 | ₹22 Cr | 36.12 | |
| Mar2024 | ₹16 Cr | 7.24 | |
| Mar2023 | ₹15 Cr | -13.08 | |
| Mar2022 | ₹17 Cr | - | |
Compare Appropriations of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹171.6 Cr | -1.3% | 29.4% | 17.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -1.3% |
29.4% |
17.2% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses